John Rozich is a Cardiology physician. OpenAlex indexes 36 publications with 1,876 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
21 E Hospital St
Manning, SC 291023152
Telephone
803-883-5171Provider last certified this registry record 1 Aug 2023.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20251 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
80.7%Beta blocker23.3%Metoprolol Succinate61%Carvedilol34%Metoprolol Tartrate2%Sotalol2%Labetalol Hcl2%Part D<11 patientsCalcium channel blocker9.9%Amlodipine Besylate61%Nifedipine Er34%Diltiazem 12hr Er2%Diltiazem 24hr Er (Cd)2%Part D<11 patients+ 16 more classes in this area
Blood & clotting
16.8%Factor Xa inhibitor12.4%Eliquis91%Xarelto9%Part D≥127 patientsP2Y12 inhibitor4.4%Clopidogrel100%Part D≥75 patientsMetabolism & gastrointestinal
2.2%SGLT2 inhibitor1.5%Jardiance83%Farxiga17%Part D<11 patientsPotassium supplement0.5%Potassium Chloride100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Amiodarone Toxicity Screening: What are the Clinicians Supposed to Tell Patients
Journal of Cardiology Research Review & Reports
2020 - Heart failure: Precision in diagnosis and therapy defining heart failure with preserved ejection fraction?
Clinical and Medical Investigations
2019 - Mitral valve prolapse: The evolution of a misunderstood entity
Clinical and Medical Investigations
2019 - Aortic Stenosis: New complexity found in an “Old Friend” The clinical challenges of correct assessment and therapy of aortic stenosis
Clinical and Medical Investigations
2019
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”